The First Nasal Treatment for Anaphylaxis: FDA APPROVED!

Mohamad-Ali Salloum, PharmD • August 17, 2024

Share

Anaphylaxis is a severe, life-threatening allergic reaction that can occur rapidly, requiring immediate medical intervention. Traditionally, epinephrine autoinjectors have been the standard of care for such emergencies. However, the recent approval by the U.S. Food and Drug Administration (FDA) of a novel nasal spray, named neffy, marks a significant milestone in the management of anaphylactic reactions

What is Neffy?


Neffy (epinephrine nasal spray) is the first of its kind for the emergency treatment of allergic reactions (Type I), including anaphylaxis, in adult and pediatric patients who weigh at least 30 kilograms (approximately 66 pounds). This approval is particularly noteworthy as it introduces the first non-injectable form of epinephrine, potentially reducing barriers to rapid treatment due to needle phobia

Why Neffy was approved?


The approval of Neffy was based on four studies involving 175 healthy adults, which demonstrated that the epinephrine concentrations in the blood following administration of Neffy were comparable to those achieved with approved epinephrine injection products. Additionally, Neffy showed similar increases in blood pressure and heart rate, which are critical effects of epinephrine in treating anaphylaxis.

How is it Administered?


Neffy is administered as a single dose nasal spray into one nostril and may be given a second dose if symptoms do not improve or worsen. It is important to note that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of Neffy. In such cases, patients are advised to consult with healthcare professionals regarding the use of injectable epinephrine products

Conclusion:


The introduction of neffy is a welcome addition to the arsenal of anaphylaxis treatments, offering a needle-free alternative that may encourage more timely administration of life-saving epinephrine. As with any new medical product, ongoing monitoring and real-world data will be essential to assess the long-term efficacy and safety of this innovative treatment option.


References :


-FDA Approves First Nasal Spray for Treatment of Anaphylaxis.


Link: https://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis


List of Services


    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD October 27, 2025
    Discover why social media is so addictive, its impact on mental health, productivity, and relationships, and practical tips to regain control and break free from the endless scroll.
    By Mohamad-Ali Salloum, PharmD October 24, 2025
    Discover how a nanoparticle-based “super vaccine” prevented melanoma, pancreatic, and breast cancers in mice. Learn the science, real-world implications, and what’s next for cancer prevention.
    By Mohamad-Ali Salloum, PharmD October 22, 2025
    Discover how mild stress can boost longevity through hormesis. Learn the science behind protective RNAs, real-life success stories, and practical tips for healthy aging.
    By Mohamad-Ali Salloum, PharmD October 20, 2025
    Lipitor's rise and Humira's record-breaking revenue—exploring pharma's biggest blockbusters and their impact.
    By Mohamad-Ali Salloum, PharmD October 19, 2025
    Smart strategies to stay sharp in the age of intelligent tools
    By Mohamad-Ali Salloum, PharmD October 19, 2025
    Discover how Microsoft Copilot can help med students create professional PowerPoint presentations in minutes. Learn workflows, prompts, and tips to automate slide decks for lectures, research, and case studies.
    By Mohamad-Ali Salloum, PharmD October 18, 2025
    Learn the timeline and objectives of clinical trial phases from preclinical to Phase 4. Understand key milestones, duration, and regulatory insights from FDA, EMA, and ICH guidelines.
    By Mohamad-Ali Salloum, PharmD October 14, 2025
    Feeling stressed or low? Science says movement beats medication. Discover why exercise is 1.5× more effective for mental health—and how to start today.
    The Power of Small Steps in Achieving Big Goals
    By Mohamad-Ali Salloum, PharmD October 14, 2025
    Learn how small steps—drinking more water, reading one page daily, or saving $1—compound over time into big achievements in health, work, and personal growth.
    By Mohamad-Ali Salloum, PharmD October 11, 2025
    Unlock the power of AI to simplify complex medical research. Learn how ChatGPT helps professionals and students quickly understand scientific papers with ease.
    More Posts